Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 450

1.

Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus.

Doe K, Nozawa K, Hiruma K, Yamada Y, Matsuki Y, Nakano S, Ogasawara M, Nakano H, Ikeda T, Ikegami T, Fujishiro M, Kawasaki M, Ikeda K, Amano H, Morimoto S, Ogawa H, Takamori K, Sekigawa I, Takasaki Y.

Lupus. 2014 Sep;23(10):1031-41. doi: 10.1177/0961203314536245. Epub 2014 May 16.

PMID:
24836587
2.

High frequency of Smith autoantibodies in Omani patients with systemic lupus erythematosus.

Al-Jabri AA, Al-Gahdani AK, Al-Shuaili I.

Rheumatol Int. 2009 Nov;30(1):51-6. doi: 10.1007/s00296-009-0909-4.

PMID:
19360411
3.

Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.

Wang H, Li T, Chen S, Gu Y, Ye S.

Arthritis Rheumatol. 2015 Dec;67(12):3190-200. doi: 10.1002/art.39296.

4.

Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.

Pradhan VD, Patwardhan MM, Ghosh K.

Indian J Dermatol Venereol Leprol. 2010 Mar-Apr;76(2):145-9. doi: 10.4103/0378-6323.60558.

5.

Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.

Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC.

Arthritis Res Ther. 2006;8(6):R162.

6.

Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.

Chauhan SK, Singh VV, Rai R, Rai M, Rai G.

J Clin Immunol. 2013 Jul;33(5):954-64. doi: 10.1007/s10875-013-9887-0. Epub 2013 Apr 7.

PMID:
23564191
7.

Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.

Saigal R, Goyal LK, Agrawal A, Mehta A, Mittal P, Yadav RN, Meena PD, Wadhvani D.

J Assoc Physicians India. 2013 Jun;61(6):372-7.

PMID:
24640201
8.

BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.

Bardin N, Desplat-Jego S, Daniel L, Jourde Chiche N, Sanmarco M.

Autoimmunity. 2009 Jan;42(1):63-8. doi: 10.1080/08916930802354906.

PMID:
19127456
9.

Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.

Julkunen H, Ekblom-Kullberg S, Miettinen A.

Rheumatol Int. 2012 Aug;32(8):2445-51. doi: 10.1007/s00296-011-1962-3. Epub 2011 Jun 26.

PMID:
21706294
10.

A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.

Pradhan V, Mahant G, Rajadhyaksha A, Surve P, Rajendran V, Patwardhan M, Nadkarni A, Dighe S, Ghosh K.

Rheumatol Int. 2013 May;33(5):1193-9. doi: 10.1007/s00296-012-2519-9. Epub 2012 Sep 13.

PMID:
22971892
11.

Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.

Al Arfaj AS, Chowdhary AR, Khalil N, Ali R.

Clin Immunol. 2007 Jul;124(1):83-9. Epub 2007 May 30.

PMID:
17540620
12.

Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.

Jimenez-Boj E, Kedersha N, Tohidast-Akrad M, Karlhofer FM, Stummvoll G, Zimmermann C, Ulrich W, Guiducci S, Hoefler E, Aringer M, Schett G, Matucci-Cerinic M, Smolen JS, Steiner G.

Arthritis Rheum. 2008 May;58(5):1226-36. doi: 10.1002/art.23435.

13.

Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden.

Eriksson C, Kokkonen H, Johansson M, Hallmans G, Wadell G, Rantapää-Dahlqvist S.

Arthritis Res Ther. 2011 Feb 22;13(1):R30. doi: 10.1186/ar3258.

14.

Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.

Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.

Scand J Rheumatol. 2007 Jul-Aug;36(4):291-8.

PMID:
17763207
15.

Increased serum APRIL differentially correlates with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.

Boghdadi G, Elewa EA.

Rheumatol Int. 2014 Sep;34(9):1217-23. doi: 10.1007/s00296-014-3020-4. Epub 2014 Apr 21.

PMID:
24748505
16.

Preliminary clinical measurement of the expression of B-cell activating factor in Chinese systemic lupus erythematosus patients.

Lin Z, Dan-Rong Y, Xiao-Qing T, Hao W, Hong-Lian G, Xian-Tao K, Ren-Qian Z, Jiyu L.

J Clin Lab Anal. 2007;21(3):183-7.

PMID:
17506477
17.

Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.

Chauhan SK, Rai R, Singh VV, Rai M, Rai G.

Immunol Lett. 2015 Dec;168(2):254-9. doi: 10.1016/j.imlet.2015.09.016. Epub 2015 Oct 3.

PMID:
26434792
18.

Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.

Wirestam L, Schierbeck H, Skogh T, Gunnarsson I, Ottosson L, Erlandsson-Harris H, Wetterö J, Sjöwall C.

Arthritis Res Ther. 2015 Nov 23;17:338. doi: 10.1186/s13075-015-0856-2.

19.
20.

Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.

Morimoto S, Nakano S, Watanabe T, Tamayama Y, Mitsuo A, Nakiri Y, Suzuki J, Nozawa K, Amano H, Tokano Y, Kobata T, Takasaki Y.

Rheumatology (Oxford). 2007 Jul;46(7):1083-6. Epub 2007 May 11.

PMID:
17500077

Supplemental Content

Support Center